These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 12657126)
41. Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy. Huh WK; Powell M; Leath CA; Straughn JM; Cohn DE; Gold MA; Falkner CA; Carey DE; Herzog T; Fowler JM; Partridge EE; Kilgore LC; Alvarez RD Gynecol Oncol; 2003 Dec; 91(3):470-5. PubMed ID: 14675664 [TBL] [Abstract][Full Text] [Related]
42. Incidence of omental metastasis in uterine serous carcinoma: a systematic review and meta-analysis. Xu H; Cui SS; Ran L; Liu Y; Hu C; Xu Y; Tian Y J Gynecol Obstet Hum Reprod; 2022 Jun; 51(6):102395. PubMed ID: 35489712 [TBL] [Abstract][Full Text] [Related]
43. Noninvasive papillary serous carcinoma of the endometrium. Gehrig PA; Groben PA; Fowler WC; Walton LA; Van Le L Obstet Gynecol; 2001 Jan; 97(1):153-7. PubMed ID: 11152925 [TBL] [Abstract][Full Text] [Related]
44. Uterine Serous Carcinomas Frequently Metastasize to the Fallopian Tube and Can Mimic Serous Tubal Intraepithelial Carcinoma. Kommoss F; Faruqi A; Gilks CB; Lamshang Leen S; Singh N; Wilkinson N; McCluggage WG Am J Surg Pathol; 2017 Feb; 41(2):161-170. PubMed ID: 27776011 [TBL] [Abstract][Full Text] [Related]
45. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy. Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561 [TBL] [Abstract][Full Text] [Related]
46. FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival. Memarzadeh S; Holschneider CH; Bristow RE; Jones NL; Fu YS; Karlan BY; Berek JS; Farias-Eisner R Int J Gynecol Cancer; 2002; 12(5):454-8. PubMed ID: 12366662 [TBL] [Abstract][Full Text] [Related]
47. Mean nuclear volume in ovarian papillary serous cystadenocarcinoma. Mohanty SK; Dey P; Saha SC Anal Quant Cytol Histol; 2004 Feb; 26(1):28-30. PubMed ID: 15032078 [TBL] [Abstract][Full Text] [Related]
48. Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinoma. Gupta D; Gunter MJ; Yang K; Lee S; Zuckerwise L; Chen LM; Goldberg GL; Huang GS Int J Gynecol Cancer; 2011 Apr; 21(3):529-34. PubMed ID: 21436701 [TBL] [Abstract][Full Text] [Related]
50. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients. Grice J; Ek M; Greer B; Koh WJ; Muntz HG; Cain J; Tamimi H; Stelzer K; Figge D; Goff BA Gynecol Oncol; 1998 Apr; 69(1):69-73. PubMed ID: 9571001 [TBL] [Abstract][Full Text] [Related]
51. Axillary lymphadenopathy as the primary presentation of primary peritoneal carcinoma. Berker B; Ortac F; Ataoglu O Gynecol Obstet Invest; 2002; 54(4):232-6. PubMed ID: 12592068 [TBL] [Abstract][Full Text] [Related]
52. The role of omentectomy and random peritoneal biopsies as part of comprehensive surgical staging in apparent early-stage epithelial ovarian cancer. Lee JY; Kim HS; Chung HH; Kim JW; Park NH; Song YS Ann Surg Oncol; 2014 Aug; 21(8):2762-6. PubMed ID: 24770785 [TBL] [Abstract][Full Text] [Related]
53. The omentum and omentectomy in epithelial ovarian cancer: a reappraisal. Part I--Omental function and history of omentectomy. Ben Arie A; McNally L; Kapp DS; Teng NN Gynecol Oncol; 2013 Dec; 131(3):780-3. PubMed ID: 24056004 [TBL] [Abstract][Full Text] [Related]